In the relentless pursuit of innovative therapeutics, in vivo studies are used to profile compound candidates from hit-to-lead to clinical candidate selection. These investigations bridge the gap between laboratory findings and human applications, providing invaluable insights into a drug’s safety, efficacy, and overall performance within a living organism.

At Welab Barcelona, our highly skilled, industry trained, in vivo pharmacology team has extensive experience in pre-clinical drug development and provides comprehensive solutions tailored to your research needs. We provide the most robust and innovative pre-clinical models and efficacy testing services to advance your research. Taking advantage of all the complementary capabilities of Welab, we can determinate efficacy, MoA, PK, PK/PD, bioavailability, organ exposure, in vivo metabolism, and potential toxicity in rodent models.

As a flexible and responsive organization, we meet the specific needs of your project. We can support you from the delivery of a stand-alone study to planning, designing, and executing a customized in vivo study in the most appropriate model.

Dear colleagues, collaborators, and friends,

After more than 30 years of shared endeavours, in which we have grown personally and professionally, and with our emotions on the surface, we announce the closure of our company. We have travelled together through ups and downs, celebrated successes and overcome challenges as a team.

We extend our deepest gratitude to each of you for your dedication, passion, and commitment to a shared goal: discovering new treatments for the benefit and well-being of patients.

As we bid farewell, let’s cherish the memories we’ve created, the bonds we’ve formed, and the impact we’ve made together. Though our paths may diverge, the spirit of collaboration and camaraderie that defines our community will always endure.

We leave proud of the work accomplished and thank you for being an integral part of our journey, wishing you success in all your future challenges.

With heartfelt appreciation,

Welab’s team

We are proud to announce that Welab is partner of this new EU funded project.

In collaboration with 12 partners from 6 countries, Welab Barcelona is establishing the Antivirus Pandemic Preparedness EuropeAn pLatform (APPEAL), a European research initiative aimed at enhancing preparedness for future pandemics. This EU funded collaboration will establish a comprehensive program for the development of broad-spectrum antiviral drugs within a five year time frame ensuring drug affordability and accessibility to low income countries.
Link to the press release: https://lnkd.in/d-jmV2CS